"smoking and drinking � giving these kids a little bit longer to make good decisions in their lives � i'm all for that," bruschi said.
.samantha long
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
published on: may 17, 2018 | last updated: may 17, 2018 5:42 pm pdt